Modulation of pathogenicity

US7335779B2 · kind B2 · utility

Assignee

• Quonova, LLC · US

Inventors

• Aldo Ammendola · Birkenfeld, DE
• Katharina Aulinger-Fuchs · Schwanau, DE
• Astrid Gotschlich · Birkenfeld, DE
• Bernd Kramer · Aachen, DE
• Martin Lang · Bogen, DE
• Wael Saeb · Gräfelfing, DE
• Udo Sinks · Birkenfeld, DE
• Andreas Wuzik · Untermeitingen, DE

Key dates

• Filing date: May 6, 2003
• Grant date: Feb 26, 2008
• Expiry date: Aug 5, 2024

Classification

• Technology area (CPC Y): Emerging Cross-Sectional Technologies
• CPC primary: Y02A50/30
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

The present invention relates to the use of compounds of the general Formula (I):wherein in Formula (I),